Vivicells International Stock Analysis

VCII Stock  USD 0.0001  0.00  0.00%   
ViviCells International is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of ViviCells International stock analysis is to determine its intrinsic value, which is an estimate of what ViviCells International is worth, separate from its market price. There are two main types of ViviCells International's stock analysis: fundamental analysis and technical analysis.
The ViviCells International stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ViviCells International's ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.

ViviCells Stock Analysis Notes

The company had not issued any dividends in recent years. ViviCells International had 1:140 split on the 9th of May 2008. ViviCells International, Inc. operates as a stem cell preservation company. The company was incorporated in 1995 and is based in Evanston, Illinois. VIVICELLS INTERNATIONAL operates under UtilitiesRenewable classification in the United States and is traded on PNK Exchange. It employs 16 people. For more information please call Kenneth Wulwick at 504-241-4400 or visit https://www.vivicells.com.

ViviCells International Investment Alerts

ViviCells International generated a negative expected return over the last 90 days
ViviCells International has some characteristics of a very speculative penny stock
ViviCells International has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.77 M. Net Loss for the year was (14.44 K) with profit before overhead, payroll, taxes, and interest of 1.13 M.
ViviCells International currently holds about 10.26 K in cash with (1.21 M) of positive cash flow from operations.

ViviCells Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 23.39 K.

ViviCells Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.46 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.46.

Technical Drivers

In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of ViviCells International, as well as the relationship between them.

ViviCells International Price Movement Analysis

java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as ViviCells International price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

ViviCells International Outstanding Bonds

ViviCells International issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ViviCells International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ViviCells bonds can be classified according to their maturity, which is the date when ViviCells International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About ViviCells Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ViviCells International prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ViviCells shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ViviCells International. By using and applying ViviCells Stock analysis, traders can create a robust methodology for identifying ViviCells entry and exit points for their positions.
ViviCells International, Inc. operates as a stem cell preservation company. The company was incorporated in 1995 and is based in Evanston, Illinois. VIVICELLS INTERNATIONAL operates under UtilitiesRenewable classification in the United States and is traded on PNK Exchange. It employs 16 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ViviCells International to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Latest Portfolios Now

   

Latest Portfolios

Quick portfolio dashboard that showcases your latest portfolios
All  Next Launch Module

Complementary Tools for ViviCells Stock analysis

When running ViviCells International's price analysis, check to measure ViviCells International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViviCells International is operating at the current time. Most of ViviCells International's value examination focuses on studying past and present price action to predict the probability of ViviCells International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViviCells International's price. Additionally, you may evaluate how the addition of ViviCells International to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities